208 related articles for article (PubMed ID: 5964006)
1. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
[No Abstract] [Full Text] [Related]
2. [Specific prophylaxis in measles. I. Preparation of a vaccine with modified live virus (strain M60-5 Huang)].
Cajal N; Cepleanu M; Sorodoc Y
Stud Cercet Inframicrobiol; 1966; 17(5):371-6. PubMed ID: 5964005
[No Abstract] [Full Text] [Related]
3. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
[No Abstract] [Full Text] [Related]
4. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
[No Abstract] [Full Text] [Related]
5. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
[No Abstract] [Full Text] [Related]
6. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
[No Abstract] [Full Text] [Related]
7. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
Egami T
Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
[No Abstract] [Full Text] [Related]
8. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
Boué A; Celers J
Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
[No Abstract] [Full Text] [Related]
9. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
[No Abstract] [Full Text] [Related]
10. Antibody response after measles immunization.
Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
[TBL] [Abstract][Full Text] [Related]
11. Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine.
McMurray DN; Loomis SA; Casazza LJ; Rey H
Bull Pan Am Health Organ; 1979; 13(1):52-7. PubMed ID: 427297
[No Abstract] [Full Text] [Related]
12. Live measles vaccine from a further attenuated strain SEVAC.
Mares I; Drevo M; Adam E; Kubátová M; Casny J
Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
[No Abstract] [Full Text] [Related]
13. The development and the study of live measles vaccine from highly attenuated strain Enders-Schwarz-Chumakov (ESC).
Chumakov MP; Voroshilova MK; Grachev VP; Dzagurov SG; Sinyak KM
Prog Immunobiol Stand; 1967; 3():194-5. PubMed ID: 5379939
[No Abstract] [Full Text] [Related]
14. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children.
Black FL; Gudnadóttir M
Bull World Health Organ; 1966; 35(6):955-7. PubMed ID: 4165239
[No Abstract] [Full Text] [Related]
15. [Results of the first trials of measles vaccination in France, with the hyperattenuated live cirus vaccine (Schwartz strain)].
Mande R; Jammet ML; Celers J; Boué A
Arch Fr Pediatr; 1967 Jan; 24(1):105-6. PubMed ID: 6031447
[No Abstract] [Full Text] [Related]
16. Seroconversion following measles immunisation.
Mittal SK; Gulati A; Kumari P; Bala V; Gupta S
Indian Pediatr; 1979 Apr; 16(4):309-11. PubMed ID: 511301
[No Abstract] [Full Text] [Related]
17. [Clinical immunoserological study of combined innoculation of inactivated and live measles vaccines].
Yamazaki Y
Nihon Shonika Gakkai Zasshi; 1969 May; 73(5):644-55. PubMed ID: 5817193
[No Abstract] [Full Text] [Related]
18. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
[TBL] [Abstract][Full Text] [Related]
19. [Trials of vaccination against measles with live and attenuated virus].
Albano A; De Donato S; Nodari R; Criscuolo A
G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500
[No Abstract] [Full Text] [Related]
20. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines.
Bellanti JA; Sanga RL; Klutinis B; Brandt B; Artenstein MS
N Engl J Med; 1969 Mar; 280(12):628-33. PubMed ID: 4179401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
